1. Home
  2. PBFS vs EOLS Comparison

PBFS vs EOLS Comparison

Compare PBFS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Bancorp Inc.

PBFS

Pioneer Bancorp Inc.

HOLD

Current Price

$14.00

Market Cap

333.8M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.03

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBFS
EOLS
Founded
1889
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.8M
284.3M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
PBFS
EOLS
Price
$14.00
$4.03
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
11.8K
1.1M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
36.07
1.23
EPS
0.83
N/A
Revenue
$15,814,000.00
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
$16.87
N/A
Revenue Growth
5.76
11.61
52 Week Low
$10.60
$3.86
52 Week High
$15.18
$12.28

Technical Indicators

Market Signals
Indicator
PBFS
EOLS
Relative Strength Index (RSI) 52.61 37.79
Support Level $12.89 N/A
Resistance Level $14.22 $4.99
Average True Range (ATR) 0.45 0.23
MACD 0.04 -0.07
Stochastic Oscillator 54.63 12.83

Price Performance

Historical Comparison
PBFS
EOLS

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: